MMedication Read More FDA sends letter to Novo Nordisk over potential GLP-1 side effectsMarch 13, 2026 The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
MMedication Read More FDA sends letter to Novo Nordisk over potential GLP-1 side effectsMarch 13, 2026 The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
MMedication Read More Has anyone died from taking GLP-1 weight-loss drugs? – Baltimore SunMarch 6, 2026 Has anyone died from taking GLP-1 weight-loss drugs? Baltimore SunObesity Injectables Linked to Gallstone Disease Surge 조선일보GLP-1 Weight-Loss Drugs Linked…
MMedication Read More Table 2.0: Restaurants absorb ‘Ozempic effect’ for weight-loss drug consumersFebruary 23, 2026 New Delhi:Dozens of Indian restaurants and cafe chains are fast-tracking Size O menus — the O standing for…
MMedication Read More Dr Reddy’s says Wegovy copycat to be priced competitively, with 50-60pc discounts feasibleFebruary 18, 2026 HYDERABAD, Feb 18 — Indian drugmaker Dr Reddy’s Laboratories hopes to launch a generic version of Novo Nordisk’s…
MMedication Read More New drug CagriSema leads to 14% weight loss in trialFebruary 10, 2026 Share on PinterestNew combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to…
MMedication Read More Health Canada warns of fake semaglutide drugs, cites ‘product safety’ risks – NationalJanuary 23, 2026 Descrease article font size Increase article font size Health Canada is warning Canadians of the dangers of buying…
MMedication Read More What is ‘natural Ozempic’ – and how good is the science?January 12, 2026 A food-oil supplement called Elcella can work like a weight-loss jab, it has been claimed – but experts say…
MMedication Read More Eli Lilly Drug Retatrutide Clinical Trial ResultsDecember 17, 2025 Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become…
MMedication Read More Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event riskNovember 28, 2025 1. In this cohort study, dulaglutide, semaglutide, and tirzepatide demonstrated similar risks of gastrointestinal adverse events (AEs) in…
MMedication Read More Weight-loss drugs: From a trickle to a floodNovember 18, 2025 It’s been varyingly called the “fat shot”, “skinny jab” or “magic pill” by politicians and celebrities who’ve put…
MMedication Read More Loss of Appetite May Result in Loss of Margins for Swiggy, Zomato – outlookbusiness.comNovember 7, 2025 Loss of Appetite May Result in Loss of Margins for Swiggy, Zomato outlookbusiness.comThe discovery that launched a new wave…